Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in Rhodopsin

Kaukonen M. et al, (2022), Genes, 13, 1327 - 1327

The Effect of Cataract on Color Vision Measurement with the Low-Vision Cambridge Colour Test: Providing an Adjustment Factor for Clinical Trials.

Jolly JK. et al, (2022), Ophthalmol Sci, 2

Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant.

Bellingrath J-S. et al, (2022), Ophthalmic Genet, 1 - 10

Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry.

Buckley TMW. et al, (2022), Transl Vis Sci Technol, 11

EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.

Feenstra HMA. et al, (2022), Retina (Philadelphia, Pa.), 42, 721 - 729

Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids.

McClements ME. et al, (2022), Transl Vis Sci Technol, 11

Bioengineering strategies for restoring vision.

Cehajic-Kapetanovic J. et al, (2022), Nat Biomed Eng

Outer retinal and choriocapillaris modifications in choroideremia: three differentially impaired retinal regions and the potential diagnostic role of the external limiting membrane.

Arrigo A. et al, (2022), Eye (London, England)

The Scope of Pathogenic ABCA4 Mutations Targetable by CRISPR DNA Base Editing Systems—A Systematic Review

Piotter E. et al, (2022), Frontiers in Genetics, 12

Choroideremia and Other Hereditary Conditions Manifesting with Choroidal Atrophy

Song WK. et al, (2022), Albert and Jakobiec's Principles and Practice of Ophthalmology: Fourth Edition, 3997 - 4012

Gene therapy and treatment trials

MacLaren RE. and Cehajic-Kapetanovic J., (2022), Clinical Ophthalmic Genetics and Genomics, 63 - 66

Rapid Quantification of the Binocular Visual Field for Clinical Trials: Performance of a Modified Esterman Supra-Threshold Test Implemented with the Open Perimetry Interface.

Andrews CD. et al, (2022), Clin Ophthalmol, 16, 1513 - 1523

RNA gene editing in the eye and beyond: The neglected tool of the gene editing armatorium?

Han RC. and MacLaren RE., (2022), International Review of Cell and Molecular Biology

Retinal cadherins and the retinal cadherinopathies: current concepts and future directions

YUSUF I. et al, (2021), Progress in Retinal and Eye Research

Clinical applications of microperimetry in RPGR ‐related retinitis pigmentosa: a review

Buckley TMW. et al, (2021), Acta Ophthalmologica, 99, 819 - 825

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa

Orlans HO. et al, (2021), Nature Communications, 12

In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention.

Bellingrath J-S. et al, (2021), Genes (Basel), 12

First-In-Human Robot-Assisted Subretinal Drug Delivery Under Local Anaesthesia A Randomised Clinical Trial.

Cehajic-Kapetanovic J. et al, (2021), Am J Ophthalmol

Structural and Functional Characteristics of Color Vision Changes in Choroideremia

Jolly JK. et al, (2021), Frontiers in Neuroscience, 15, 1287 - 1287

CRISPR Systems Suitable for Single AAV Vector Delivery.

Stevanovic M. et al, (2021), Curr Gene Ther

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?